Arkolith/Insider Trading/ADIL/Form 4

Schuyler Kevin

DirectorADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Oct 3, 2023
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 29, 2023Buy(P)700$2.74$2K700

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001013762-23-000757) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML